NASDAQIndustrialsAgricultural - MachinerySnapshot 2026-10-23
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
A matching fiscal period and sufficient coverage are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least five analysts and a baseline within three days of the requested lookback.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Gross profit improvement to maintain or exceed Q1 2026 level | Gross profit nearly doubled from $944K to $1.91M. | Improving | gross profit falls below $944K in any quarter next year | Gross profit: $1.66M FY2026-Q3; GAAP. Published target: >= $1.91 million in next 4 quarters. Target period is not explicitly aligned with this observation. Source published Oct 13, 20261,660,490 USD · source valueSource reportLast status assessment Oct 24, 2026Measurement sourceconsolidated · GAAP FY2026-Q3 · Period ending Aug 31, 2026 Source: company_financial_results. Reference: 09e1145c-1d56-4a81-a1e6-90e9b1cdfb98. Source status: eligible. Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated as a priority in 3 of last 3 quarters. Consolidated gross margin declined by 2.1% to 27.9% in 2026-Q3 compared to 2025-Q3. Agricultural Products margin improved by 4.0%, but Modular Buildings margin declined by 9.2% over the same period. Management acknowledges cost pressures and is actively working on margin recovery, indicating mixed progress with ongoing challenges. Delivery assessment Oct 24, 2026 |
Positive cash flow from operations sustained | Cash flow from operations turned positive from negative $889K to $148K. | Improving | cash flow from operations falls below $0 in any quarter next year | Cash from operations: $1.338M FY2026-Q3; GAAP. Published target: >= $0 in next 4 quarters. Target period is not explicitly aligned with this observation. Source published Oct 13, 20261,337,812 USD · source valueSource reportLast status assessment Oct 24, 2026Measurement sourceconsolidated · GAAP FY2026-Q3 · Period ending Aug 31, 2026 Source: stock_quarterly_financials_fmp. Reference: 2026-Q3. Source status: unverified. Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Revenue growth to sustain above prior quarter level | A primary condition in ARTS WAY MANUFACTURING CO INC's published investment case. The stated target is >= $6.64 million in next 4 quarters. | Intact | revenue falls below $5.07 million in any quarter next year | Revenue: $5.615M FY2026-Q3; GAAP. Published target: >= $6.64 million in next 4 quarters. Target period is not explicitly aligned with this observation. Source published Oct 13, 20265,615,156 USD · source valueSource reportLast status assessment Oct 24, 2026Measurement sourceconsolidated · GAAP FY2026-Q3 · Period ending Aug 31, 2026 Source: company_financial_results. Reference: 09e1145c-1d56-4a81-a1e6-90e9b1cdfb98. Source status: eligible. Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated as a priority in 3 of last 3 quarters. Consolidated revenue grew from $17.91 million in 2025-Q3 to $20.11 million in 2026-Q3 (+12.3%). Agricultural Products sales increased 12.4% year-over-year in the same period. Management's repeated emphasis on demand growth and optimistic outlook aligns with the revenue growth trajectory, indicating delivering progress. Delivery assessment Oct 24, 2026 |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Compare these dated observations with the operating requirements above
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsMonthly analyst history is unavailable.
Recent actions · Sep 25–Oct 24 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earnings3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
ARTW is a small industrial business with growth progress but elevated execution risk, rather than a proven durable compounder. Its long-term thesis is on watch: revenue and backlog are advancing, but earnings remain loss-making and confidence is medium.
The evidence describes ARTW as cheap versus peers, with a near-neutral expectations gap. The valuation signal is medium confidence, and no fragility gates are flagged, so the evidence does not point to unusually concentrated market expectations.
In the near term, revenue growth and a sharp rise in Modular Buildings backlog show progress, but consolidated gross margin declined and segment margin results were mixed. Earnings risk is elevated, with a stated 65% chance of a next-quarter miss; a guidance cut would be a meaningful negative. Over the multi-year view, execution on backlog and margin recovery matters, while recent performance remains below the industry cohort.
The thesis depends on whether ARTW can convert Modular Buildings commitments into sales and improve margins amid cost pressure. Near-term results also hinge on guidance and earnings execution. Strength or weakness among industrial bellwethers such as CAT, DE, and CNH could affect the sector backdrop.
Over the next one to three years, ARTW has evidence of growth progress, but loss-making results, margin challenges, and elevated near-term earnings risk leave the long-term thesis uncertain. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.